October 15, 2015
October 15, 2015 —
An international team of researchers has identified a new molecule involved in skin fibrosis, a life-threatening disease characterized by the inflammation and hardening of skin tissue. The new study is the first to investigate the role of this molecule in skin fibrosis and paves the way toward new and improved…
February 26, 2016
February 26, 2016 —
When astronaut Scott Kelly returns to Earth on March 1, half of NASA’s first-of-its-kind study of twin astronauts and long duration space flight, researchers at University of California, San Diego School of Medicine and elsewhere will launch the mission’s next phase.
May 2, 2016
May 2, 2016 —
When the master pacemaker that normally synchronizes circadian rhythms in the brain is disrupted, that disruption causes helplessness, behavioral despair, and anxiety-like behavior in mice, say scientists at the University of California San Diego.
May 2, 2016
May 2, 2016 —
Oncternal Therapeutics, a new cancer-focused biotechnology startup, has signed a wide-ranging licensing agreement with UC San Diego to develop and commercialize antibodies and antibody-related binding agents.
May 17, 2016
May 17, 2016 —
While investigating a potential therapeutic target for the ERK1 and 2 pathway, a widely expressed signaling molecule known to drive cancer growth in one third of patients with colorectal cancer, University of California San Diego School of Medicine researchers found that an alternative pathway immediately emerges when ERK1/2 is halted,…
May 23, 2016
May 23, 2016 —
The U.S. Department of Energy has ranked UC San Diego’s algae biofuels research effort the number one program in the nation for the fourth consecutive year.
August 4, 2016
August 4, 2016 —
Robert Legaspi was 9 years old when he was first diagnosed with acute lymphoblastic leukemia (ALL). This year, at age 27, his leukemia returned for the fourth time. This time was different, though — on May 20, 2016, Legaspi became the first patient in San Diego to receive a new…
November 3, 2016
November 3, 2016 —
By removing the protein galectin-3 (Gal3), a team of investigators led by University of California School of Medicine researchers were able to reverse diabetic insulin resistance and glucose intolerance in mouse models of obesity and diabetes.
March 21, 2017
March 21, 2017 —
Standard antidepressant medications don’t work for everyone, and even when they do they are slow to kick in. In an effort to find better depression treatments, researchers at University of California San Diego School of Medicine discovered that inhibiting an enzyme called Glyoxalase 1 (GLO1) relieves signs of depression in…
April 14, 2017
April 14, 2017 —
Various studies and analyses have revealed that the remains are those of a girl between 15 and 16 years old who lived almost 13,000 years ago in what is now Mexico’s Yucatan peninsula.